April 18th 2025
Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
The Framework for Embracing Gene Therapy in Hemophilia Treatment
September 30th 2023Although gene therapy is anticipated to bring positive changes for people with hemophilia, choosing to receive gene therapy will require empowerment, participation, and shared decision-making, investigators write.
Read More
Altuviiio sBLA for Severe Hemophilia A in Children Accepted by FDA
September 29th 2023The supplemental biologics license application (sBLA) is supported by the results of the XTEND-Kids study, demonstrating a once-weekly 50 IU/kg dose of antihemophilic factor (recombinant) provides effective bleed protection in children with hemophilia A and can be used across clinical scenarios.
Read More
Dato-Dxd Shows Survival Improvements in HR+/HER2– Breast Cancer
September 29th 2023The dual primary end points of overall survival and progression-free survival were encouraging when patients with hormone receptor–positive (HR+), HER2-negative (HER2–) breast cancer were treated with datopotamab deruxtecan.
Read More
Subanalysis of ADAPT Reveals Consistent Efficacy With Efgartigimod Among All Genders
September 29th 2023Patients with generalized myasthenia gravis treated with efgartigimod consistently exceeded treatment compared with placebo regardless of gender in age, disease duration, body mass index, and thymectomy.
Read More
Surgery, Radiation for PCa Show Equal Efficacy in Candidates for Renal Transplantation
September 27th 2023A recent study suggests that patients with high-risk prostate cancer (PCa) in need of renal transplantation should receive cancer treatment before their transplants, as surgery and radiation treatment for localized PCa appear to be equally effective in this patient population.
Read More
Collaboration Is Key to Success in Alternative Payment Models, Says COA’s Nick Ferreyros
September 27th 2023The number one ingredient that an oncology-based alternative payment model needs to succeed is collaboration, explained Nicolas Ferreyros, managing director of policy, advocacy, and communications, Community Oncology Alliance (COA).
Watch
ICI Treatment Necessitates Close Monitoring of Potential Myasthenia Gravis
September 25th 2023Overactivation of the immune system is a potential serious adverse event (AE) following immune checkpoint inhibition (ICI) treatment for any of several cancers in the first and second line; among these AEs is myasthenia gravis.
Read More
Transforming Health Care: Insights From Industry Leaders on Health Equity and Policy
September 25th 2023At the National Comprehensive Cancer Network Oncology Policy Summit, prominent figures in the health care industry from diverse organizations emphasized a commitment to advancing health equity and addressing pressing social and health disparities.
Read More
What We’re Reading: RSV Vaccines for Pregnant Women; Medicaid Dental Care; Organ Transplant Bill
September 25th 2023The CDC recommends pregnant women receive RSV vaccinations; 6 states expand their Medicaid programs to offer dental coverage; a new bill aims to address issues in the US organ transplant system
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine, discusses telehealth initiatives at Duke Health, as well as overcoming virtual challenges and barriers that underserved and underinsured patient populations who need diabetes care face.
Watch
Super-Refractory Status Epilepticus Linked With Unknown Etiologies, High Mortality Rates
September 23rd 2023Patients treated for more than 28 days had a higher chance of status epilepticus cessation, but also a high risk of moderate to severe disability at discharge, according to one study.
Read More
Autonomic Dysfunction Significantly Associated With Decreased Quality of Life in MS, NMOSD
September 23rd 2023Findings showed that autonomic symptom burden was slightly more severe in patients with multiple sclerosis (MS) compared with those with NMOSD, although the difference was not statistically significant.
Read More
Breast Cancer Risk Linked to Air Pollution Exposure
September 22nd 2023Data from 6 states—California, Florida, Louisiana, New Jersey, North Carolina, and Pennsylvania—and 2 metropolitan areas—Atlanta, Georgia, and Detroit, Michigan—collected through the National Institutes of Health–AARP Diet and Health Study were used for the investigation.
Read More
Racial Differences in Chemokine Expression May Contribute to Prostate Cancer Disparities
September 22nd 2023Researchers found that analyzing certain chemokine levels may help explain racial disparities in prostate cancer lethality, and that neutralizing such chemokines could potentially benefit prostate cancer treatment.
Read More